Apple Inc. (NASDAQ:AAPL) announced ResearchKit™, a software framework designed for medical and health research that helps doctors, scientists and other researchers gather data more frequently and more accurately from participants using mobile devices, is now available to researchers and developers. The first research apps developed using ResearchKit study asthma, breast cancer, cardiovascular disease, diabetes and Parkinson’s disease, and have enrolled over 60,000 iPhone® users in just the first few weeks of being available on the App Store™.* Starting today, medical researchers all over the world will be able to use ResearchKit to develop their own apps and developers can also contribute new research modules to the open source framework.

“We are delighted and encouraged by the response to ResearchKit from the medical and research community and the participants contributing to medical research. Studies that historically attracted a few hundred participants are now attracting participants in the tens of thousands,” said Jeff Williams, Apple’s senior vice president of Operations. “Medical researchers all over the world are actively exploring how ResearchKit can help them study even more diseases, and we believe the impact on global understanding of health and wellness will be profound.”

The open source framework allows any medical researcher to take advantage of the initial modules in ResearchKit to study health and wellness and better understand disease. Developers can also build new modules based on the open source code and contribute them to ResearchKit. The initial customizable modules address the most common elements found in research studies—participant consent, surveys and active tasks.

  • Participant consent: Participant consent is a critical element to research studies, and with ResearchKit researchers can access a visual e-consent template that can be customized to explain the details of the study and obtain participant signatures. This module makes it easy for the researcher to include elements such as video segments explaining the study and an interactive quiz to confirm the participant’s understanding.
  • Surveys: The survey module provides a pre-built user interface that makes it easy to customize questions and answers for study participants to complete and immediately share with researchers.
  • Active Tasks: The Active Task module enables researchers to gather more targeted data for their study by inviting participants to perform activities that generate data using iPhone’s advanced sensors. Initial Active Task modules include tasks to measure motor activities, fitness, cognition and voice, and with the framework available as open source, the research community can contribute even more active tasks to ResearchKit.

“ResearchKit could help us reach people all over the world who are willing to contribute to medical research, but might not know how or be able to get involved,” said Ricky Bloomfield, Director of Mobile Technology Strategy and Assistant Professor in Internal Medicine & Pediatrics at Duke University. “Our team of researchers is now launching the development of an exciting new study using the ResearchKit framework, which will enable us to gather data quickly, from more participants than we are typically able to reach.”

“Because of the ubiquity of iPhone and the elegant implementation of consent, survey and instrumented data collection, ResearchKit has enormous promise for leading the transformation of how we engage patients in research,” said Kenneth Mandl, MD, MPH, of the Boston Children’s Hospital Informatics Program. “Now that we have access to the ResearchKit framework, our team can start customizing the initial modules and even design new ones for our particular study.”

ResearchKit turns iPhone into a powerful tool for medical research. When granted permission by the participant, ResearchKit apps can access data from advanced iPhone sensors like the accelerometer, gyroscope, microphone and GPS to gain insight into a participant’s activity levels, motor impairments, memory and more. ResearchKit works seamlessly with HealthKit™, a software framework Apple introduced with iOS 8 to provide developers the ability for health and fitness apps to communicate with each other. With permission from the participant, ResearchKit apps can access and use data from the Health app such as weight, blood pressure, glucose levels and asthma inhaler use, which are measured by third-party devices and apps.  (Original Source)

Shares of Apple opened today at $127 and are currently trading down at $126.24. AAPL has a 1-year high of $133.60 and a 1-year low of $73.05. The stock’s 50-day moving average is $126.66 and it’s 200-day moving average is $114.55.

On the ratings front, Apple has been the subject of a number of recent research reports. In a report released today, Argus analyst Jim Kelleher reiterated a Buy rating on AAPL, with a price target of $145, which implies an upside of 14.2% from current levels. Separately, yesterday, Cantor Fitzgerald’s Brian White maintained a Buy rating on the stock and has a price target of $180.

According to, which ranks over 7,500 financial analysts and bloggers to gauge the performance of their past recommendations, Jim Kelleher and Brian White have a total average return of 17.1% and 18.7% respectively. Kelleher has a success rate of 74.5% and is ranked #290 out of 3574 analysts, while White has a success rate of 70.0% and is ranked #29.

The street is mostly Bullish on AAPL stock. Out of 84 analysts who cover the stock, 62 suggest a Buy rating , 20 suggest a Hold and 2 recommend to Sell the stock. The 12-month average price target assigned to the stock is $137.61, which implies an upside of 8.4% from current levels.